ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 908,474 | $24,410,696 | 22.12% |
| Western Financial Corp/CA | 820,239 | $22,039,822 | 16.16% |
| JOHNSON & JOHNSON | 247,598 | $6,652,958 | 2.45% |
| WEALTH EFFECTS LLC | 164,750 | $4,426,835 | 2.19% |
| M28 Capital Management LP | 67,400 | $1,811,038 | 2.08% |
| Privium Fund Management B.V. | 259,036 | $6,960,298 | 2.07% |
| Evolutionary Tree Capital Management, LLC | 51,266 | $1,377,517 | 1.78% |
| Avidity Partners Management LP | 1,063,897 | $28,586,912 | 1.15% |
| SECTORAL ASSET MANAGEMENT INC | 157,552 | $4,233,422 | 0.82% |
| Vivo Capital, LLC | 137,411 | $3,692,234 | 0.40% |
| Rokos Capital Management LLP | 1,675,921 | $45,031,997 | 0.33% |
| MOODY ALDRICH PARTNERS LLC | 59,669 | $1,603,306 | 0.30% |
| Orbimed Advisors | 433,651 | $11,652,202 | 0.25% |
| Avoro Capital Advisors LLC | 565,000 | $15,181,550 | 0.24% |
| AIGEN INVESTMENT MANAGEMENT, LP | 35,140 | $944,212 | 0.18% |
| Bridgefront Capital, LLC | 9,005 | $241,964 | 0.17% |
| Corton Capital Inc. | 12,324 | $331,146 | 0.17% |
| OAK RIDGE INVESTMENTS LLC | 47,671 | $1,280,920 | 0.16% |
| O'ROURKE & COMPANY, Inc | 7,860 | $211 | 0.15% |
| Woodline Partners LP | 468,497 | $12,588,514 | 0.15% |
External links
This page lists ARROWHEAD PHARMACEUTICALS IN's shareholders in Q3 2023. To view ARROWHEAD PHARMACEUTICALS IN's shareholder history, click here.